Day One - CT (Central Time)
Start your journey through the complex world of government contracting with this essential primer.
- Miree Lee, MS, MBA - Bio/Pharma Pricing, Contracts & Compliance Consultant, M.Lee Consulting LLC
Comprehensive examination of core Medicaid pricing methodologies, calculation requirements, and reporting obligations that form the foundation of government pricing compliance.
- Miree Lee, MS, MBA - Bio/Pharma Pricing, Contracts & Compliance Consultant, M.Lee Consulting LLC
Examine the mechanics of state rebate programs, including documentation standards and approaches to processing both standard and supplemental rebates across different state systems.
- Josephine Hawkins - Director, Medicaid, AstraZeneca
- Dive deep into Advanced AMP calculation scenarios using real-world, blinded case studies
- Explore the impact of 70/30 calculations on AMP and learn strategic modeling techniques
- Interactive workshop featuring insights from industry experts and legal perspectives
- Practical guidance for navigating complex manufacturer pricing calculations
- Amanda Tucker - Associate Director, Solution Delivery, Northridge Insight
- Quantify 340B impact, optimize rebate compliance, mitigate reimbursement risks
- Evaluate specialty pharmacy partnerships, analyze exclusive distribution models, optimize channel economics
- Design adaptive pricing models, integrate medical claims data, enhance gross-to-net forecasting
- James Powell - Life Sciences Industry Director, RSM US LLP
- Josef Magpantay - Director, RSM US LLP
- Gain insight into evolving reporting obligations with a clear overview of timelines and requirements
- Trends to watch in state requirements and practical strategies for proactive compliance in a fragmented landscape
- Exploring approaches to maintain consistent, accurate reporting while responsibly addressing proprietary information consideration
- Lynetta Moore - Director, State Price Transparency Reporting, IntegriChain
- Kirsten Midtbo - Senior Manager, State Price Transparency Reporting, IntegriChain
- Learn how your peers are addressing SPTR management, operations, and compliance
- Gain more understanding of best practices that you can apply in your organization
- Hear perspectives on future developments
- John McGrory - CEO, ClassOne Insight
- Claims processing and resolving disputes in light of new IRA requirements
- State-specific formulary management and PDL decision-making processes
- Effective P&T committee presentation strategies for manufacturers
- Administrative efficiency improvements for rebate processing
- 340B claims identification and reconciliation approaches
- Navigating increased state data submission requirements and enforcement
- Coordinating implementation of new federal and state policy changes
- Missy Wheeler - Associate Director, Medicaid Operations, IQVIA
- Nichole Palusinski Pharm.D - Clinical Pharmacist, IL HFS Medicaid Drug Rebate Unit
- Cathy Burton-Meza, MJ - Associate Director, Government Rebates, Gilead Sciences
- Sherry Kindred - Senior Director Drug Rebate, Gainwell
- Antoine Nelson - Director, Pharmaceutical Rebate Operations, Government Healthcare Solutions, Conduent
- Jacqwan Goldwire - Sr. Manager, Drug Rebate Operations, Gainwell
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.
AK, AZ, AR, CA (ADAP), CO, CT (ADAP), CT (DSP), DC, GA, ID (ADAP), ID, LA, MD, MI, MT, MN, NE, NH, NY, NV, NV (ADAP), NC, PA, RI, SC, VA, WI (DSP)
- Jeanine Lundeberg - Director, Pharmacy Rebate Management, Prime Therapeutics
- Dena Karels - CPhT Lead, Manager, Rebate Dispute Management, Prime Therapeutics
- Kristin Trevathan - Supervisor, Rebate Operations, Prime Therapeutics
Essential structure for understanding 340B program eligibility, covered entity requirements, manufacturer obligations, and the fundamental principles governing this complex discount program.
- Michelle Drozd - Executive Director and Head, US Pricing Policy & Analytics, Gilead
- Heath Ingram - Partner, Goodwin
This session explores the complex and evolving requirements of recalculations and effective executive management communication. Topics include potential recalculation drivers, current regulatory requirements across Medicaid, Medicare, VA and 340B programs, agency communications, materiality considerations, executive management information needs, mitigation planning strategies, and step-by-step recalculation approaches.
- Chris Cobourn - Managing Director, Helio GP Advisory Services
- Marijo Bustos, MBA - Head of Government Pricing and Reimbursement, UCB Inc
Join a workshop to discuss the latest government updates from OIG, IRS and others.
- Discuss best practices and alternative options for documentation
- Review Department of Justice and court perspectives on FMV
- Meena Datta - Partner, Sidley Austin LLP
- Trevor Wear - Partner, Sidley Austin LLP
- Harmonizing methodologies and GP assumptions for product acquisitions, divestitures and launches
- Government program participation strategies
- Practical insights and best practices from recent experiences
- Scott Hoffman - Co-Founder & Head of Client Services, Woven Data
- Daniel Yerves - Senior Director, Market Access, Government Pricing, Contracting and Trade, scPharmaceuticals
- Mike Rowland - Senior Director, Pricing Contract and Analytics, Acadia Pharmaceuticals
Join us for this deep dive workshop into the ever-changing active and pending SPTR laws from the legal and operational perspectives.
- Gregg Kasten - Vice President, Products and Services, ClassOne Insight
Updates directly from the manufacturers, vendors and CMS folks working to improve the health ecosystem from all sides. This industry group is here to answer questions on what they do, how they do it and what they are currently working on. During this session, event organizers will compile a list of ideas on behalf of manufacturers to CMS for consideration in hopes for direct action taken by the insights of this session.
- Disha Gokani - Principal, Client Data Integrations, IQVIA
- Antoine Nelson - Director, Pharmaceutical Rebate Operations, Government Healthcare Solutions, Conduent
- Cathy Burton-Meza, MJ - Associate Director, Government Rebates, Gilead Sciences
- Josephine Hawkins - Director, Medicaid, AstraZeneca
- Lisa Norton - Associate Director, Contract Administration, Value and Access, Eli Lilly and Company
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.
Overview of Medicare Part B program structure, ASP calculation basics, and reporting requirements critical for products administered in physician offices and outpatient settings.
- Chris Weiser - Associate General Counsel, Value & Access and Pricing, Teva
- Shrutej Patel - Director of Government Pricing & Commercial Contracts, Ipsen
Introduction to Medicare's prescription drug benefit program structure, manufacturer obligations, and key calculations affecting covered medications for beneficiaries.
- Judd Caulfield - Senior Counsel, Takeda Pharmaceuticals
- Operational considerations for new pharmaceutical companies
- Explore effective organizational structures for managing 340B programs as companies grow, including cross-functional centers of excellence that bridge legal, compliance, market access, and finance responsibilities
- Darnell Turner - Vice President, Pricing, Contracting, Market Access Operations, Exelixis Inc
- Kaneshia Bell-Walton - Sr Manager, Government Pricing Reporting, McKesson
- Kim Westbrooks - Government Rebate Analyst, McKesson
- Developing Your Initial Government Pricing and Reimbursement Model
- Developing internal calculation frameworks
- Tools for accurate government pricing assessment
- Aubrey Elmore - Principal, Regulatory Compliance, IQVIA
- Oonagh O'Malley - Associate Director, Government Pricing & Reporting, Insmed Incorporated
- Kavita Gupta - Director, GP, Sandoz
- Sri Lekha Ramesh Kumar - Principal, Government Pricing, IQVIA, IQVIA
- Discuss elements of the pharmaceutical pricing agreement
- Describe 340B ceiling price calculation
- Identify pricing responsibilities with HRSA and wholesalers
- Mike Benedict, MS, RPh - Senior Vice President, Pharmacy Sourcing Operations, Apexus
- John Barnes, MBA, CPM, 340B ACE - Vice President, Pharmacy Contract Services, Apexus
- Cathy Burton-Meza, MJ - Associate Director, Government Rebates, Gilead Sciences
- Clarissa Crain - Managing Director, Deloitte & Touche
- Lisa Scholz PharmD, MBA, FACHE - Vice President, 340B Enterprise Strategy, Health System and Government Services, Cencora
- Share leading practices in good-faith inquiries
- Understand the guidelines for manufacturer audits and the dispute resolution process
- Review results of recent HRSA audits of manufacturers and covered entities
- Describe the process for developing and implementing a successful corrective action plan (CAP)
- Sanaz Kelly, PharmD, MBA, 340B ACE - Associate Principal, Manufacturer Refund Service, Apexus
- Bibi Wishart, PharmD, MBA, DPLA - Director of Pharmacy, 340B Program, Atrium Health
- Jennifer Lospinoso - Managing Director & Consulting Lead, Riparian
- Marijo Bustos, MBA - Head of Government Pricing and Reimbursement, UCB Inc
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.
Please sign up onsite at registration desk on September 15.
• Delaware • District of Columbia • Hawaii • Illinois • Kentucky • Maryland • Massachusetts • New Mexico • Indiana • Tennessee
- Nichole Palusinski Pharm.D - Clinical Pharmacist, IL HFS Medicaid Drug Rebate Unit
- Dorine Rascoe - Division Chief, Drug Rebates and Lockbox Services, Office of Finance, Medical Care Programs, Maryland Department of Health
- Tykeisha Corbett - Drug Rebate Manager, Drug Rebate and Lockbox Services Unit, Office of Finance, Maryland Department of Health
- Sherry Kindred - Senior Director Drug Rebate, Gainwell
- Antoine Nelson - Director, Pharmaceutical Rebate Operations, Government Healthcare Solutions, Conduent
- Felicia DiPaolo - Director, Medicaid Drug Rebates, MedImpact
- Kathy Thomas - Senior Manager, Drug Rebate Operations at Gainwell, Gainwell
- Heather Brown - Manager, Medicaid Drug Rebates, MedImpact
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.
Foundational knowledge of Veterans Affairs contracting requirements, pricing obligations, and essential compliance considerations for pharmaceutical manufacturers.
- Stephanie Kupski - Director US Pricing & Government Reporting, North American Commercial Operations, CSL Behring
- Funso Olufade, PhD, MBA - Former Head of US Finance and Controlling, Averitas Pharma
- Lynn Buhl - Managing Director, Riparian
Basic framework for understanding the Inflation Reduction Act's pharmaceutical provisions and initial steps toward implementing compliant processes and systems.
- Kristina Roach - Customer Success Officer, RevSavvy
- Marijo Bustos, MBA - Head of Government Pricing and Reimbursement, UCB Inc
- Strategies for launching new drugs
- Develop multi-channel market access strategies
- Elizabeth Lindquist - Partner, Arnold & Porter
- Identify price adjustment triggers across therapeutic categories
- Build scenario planning models for IP and market disruptions
- Develop dynamic pricing strategies responsive to market conditions
- Marcella Lynch - Head of Pricing, Contracting and Forecasting, Americas Rare Diseases, Chiesi USA, Inc.
- Aaron Levy - Founder, Thirdsight
- Hiram Mac - Founder, Thirdsight
- Maria Hay - Associate Director, Harrow Inc.
- Discuss covered entity inventory management models and purchasing account setups
- Identify contracting methodologies and the procurement activities related to 340B program requirements
- Michael Peters, PharmD, MBA, BCPS, 340B ACE - 340B Compliance Director, Apexus
- Explain the types of contracts loaded to covered entity purchasing accounts and drivers of purchasing from different accounts
- Identify contracting methodologies and the procurement activities related to 340B program requirements
- Broderick Olson, PharmD, MBA, MS, BCPS, 340B ACE - Brand Sourcing Director, Apexus
- Jeremy Enger, PharmD - 340B Program Manager, Allina Health
- Dave Reesman, 340B ACE - Pharmaceutical Manufacturer Consultant, .
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.
Please sign up onsite at registration desk on September 15.
• Delaware • District of Columbia • Hawaii • Illinois • Kentucky • Maryland • Massachusetts • New Mexico • Indiana • Tennessee
- Nichole Palusinski Pharm.D - Clinical Pharmacist, IL HFS Medicaid Drug Rebate Unit
- Sherry Kindred - Senior Director Drug Rebate, Gainwell
- Dorine Rascoe - Division Chief, Drug Rebates and Lockbox Services, Office of Finance, Medical Care Programs, Maryland Department of Health
- Tykeisha Corbett - Drug Rebate Manager, Drug Rebate and Lockbox Services Unit, Office of Finance, Maryland Department of Health
- Antoine Nelson - Director, Pharmaceutical Rebate Operations, Government Healthcare Solutions, Conduent
- Felicia DiPaolo - Director, Medicaid Drug Rebates, MedImpact
- Kathy Thomas - Senior Manager, Drug Rebate Operations at Gainwell, Gainwell
- Heather Brown - Manager, Medicaid Drug Rebates, MedImpact
- Steve Smith - Director, Industry Relations, Optum Rx
- Martee Blair - Rebate Director, Indiana Medicaid, OptumRx
- Michael Chien, Director - Director, Industry Relations, OptumRx
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.
- Chicago prohibition history tour with brewery visits & speakeasy visiting: Forbidden Root West Town & Haymarket Pub & Brewery
- Along the route, our experienced guide will provide you with details on each location, and they can provide interesting stories of Chicago’s bootleggers and architecture.
- Includes tastings, open bar & family-style Dinner will be provided at the second brewery including a vegetarian option. Please let the MDRP team know if you have any additional dietary restrictions, allergies.
- LIMITED: Only ~20 spots available
First to fill out this form secure a spot! Available only to registered MDRP Summit attendees
Important Accessibility Notice: We regret to inform potential participants that the Barrel Bus is custom transportation vehicle that requires entry using steps and a seating configuration without wheelchair spaces or a lift or ramp, and does not have seatbelts.